InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2025-05-16 00:00:00 ET · period of report 2025-05-15 · accession 0001055726-25-000030 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-16 2025-05-15 INO Shea Jacqueline Elizabeth CEO, Dir M - OptEx — +17.7K 67.4K +36% —
D 2025-05-16 2025-05-15 INO Shea Jacqueline Elizabeth CEO, Dir F - Tax $1.95 -7,717 59.7K -11% -$15.0K
D 2025-05-16 2025-05-15 INO Shea Jacqueline Elizabeth CEO, Dir M - OptEx $0.00 -17.7K 17.7K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-15 M A 17,744 — 67,402 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.
2 Common Common Stock 2025-05-15 F D 7,717 $1.95 59,685 D — — (F2) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
3 Derivative Restricted Stock Unit 2025-05-15 M D 17,744 $0.00 17,744 D — · — to — 17,744 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.